Please assess the completion status of the following clinical trial:

Trial Title: Augmenting Massed Prolonged Exposure With a Stellate Ganglion Block to Treat PTSD

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: EARLY_PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Active duty or retired military service member (age 18- 65 years)~2. PTSD diagnosis as assessed by Clinician-Administered Posttraumatic Stress Scale (CAPS-5)~3. Able to speak and read English (due to standardization of outcome measures)~4. Defense Enrollment Eligibility Reporting System (DEERS)-eligible to receive care at Brooke Army Medical Center for the stellate ganglion block.~Exclusion Criteria:~1. Classification as high risk for suicide~2. Current serious mental health diagnosis (e.g., bipolar or psychosis)~3. Symptoms of moderate to severe substance (to include alcohol) use within the last 30 days~4. Pregnancy (i.e. positive pregnancy test at screening) or breastfeeding~5. Current anticoagulant use~6. History of bleeding disorder~7. Infection or mass at injection site~8. Myocardial infarction within 6 months of procedure~9. Pathologic bradycardia or irregularities of heart rate or rhythm;~10. Symptomatic hypotension~11. Phrenic or laryngeal nerve palsy~12. History of glaucoma~13. Uncontrolled seizure disorder~14. History of allergy to local anesthetics

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- Stellate Ganglion Block (Type: EXPERIMENTAL): One time administration of a stellate ganglion block

Based on this trial design, predict the completion outcome and termination type (if applicable).